Pasconeural-Injektopas

Pasconeural-Injektopas Uses, Dosage, Side Effects, Food Interaction and all others data.

A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016). Pasconeural-Injektopas has also been investigated as an oral entry inhibitor in treatment-experienced HIV patients .

Pasconeural-Injektopas is an anesthetic agent indicated for production of local or regional anesthesia, particularly for oral surgery. Pasconeural-Injektopas (like cocaine) has the advantage of constricting blood vessels which reduces bleeding, unlike other local anesthetics like lidocaine. Pasconeural-Injektopas is an ester anesthetic. It is metabolized in the plasma by the enzyme pseudocholinesterase through hydrolysis into para-aminobenzoic acid (PABA), which is then excreted by the kidneys into the urine.

Trade Name Pasconeural-Injektopas
Availability Discontinued
Generic Procaine
Procaine Other Names Novocaine, Procaina, Procaine, Procainum, Vitamin H3
Related Drugs lidocaine ophthalmic, cocaine nasal, bupivacaine
Type
Formula C13H20N2O2
Weight Average: 236.3101
Monoisotopic: 236.152477894
Groups Approved, Investigational, Vet approved
Therapeutic Class
Manufacturer
Available Country Germany
Last Updated: September 19, 2023 at 7:00 am
Pasconeural-Injektopas
Pasconeural-Injektopas

Uses

Pasconeural-Injektopas is a local anesthetic used for anesthesia, peripheral nerve block, and spinal nerve block.

Used as a local anesthetic primarily in oral surgery

Pasconeural-Injektopas is also used to associated treatment for these conditions: Otalgia

How Pasconeural-Injektopas works

Pasconeural-Injektopas acts mainly by inhibiting sodium influx through voltage gated sodium channels in the neuronal cell membrane of peripheral nerves. When the influx of sodium is interrupted, an action potential cannot arise and signal conduction is thus inhibited. The receptor site is thought to be located at the cytoplasmic (inner) portion of the sodium channel. Pasconeural-Injektopas has also been shown to bind or antagonize the function of N-methyl-D-aspartate (NMDA) receptors as well as nicotinic acetylcholine receptors and the serotonin receptor-ion channel complex.

Food Interaction

No interactions found.

Pasconeural-Injektopas Disease Interaction

Moderate: cardiac rhythm disturbances

Half Life

7.7 minutes

Elimination Route

With normal kidney function, the drug is excreted rapidly by tubular excretion.

Innovators Monograph

You find simplified version here Pasconeural-Injektopas

*** Taking medicines without doctor's advice can cause long-term problems.
Share